Skip to main content

Closed

OSTX: OS Therapies Incorporated Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC407.6%

Financially safe

Stretched

Debt / equity-0.12×

Interest coverage-449.6×

Current ratio0.05×

OS Therapies Incorporated

OSTXNew York Stock Exchange Arca·USD·Closed

OS Therapies Incorporated

OSTXNew York Stock Exchange Arca·USD·Closed

$1.63

+5.16%

$1.63

+$0.08 (5.16%)

52W Range

34thpctl

Volume

0.45×avg

Mkt Cap

74.23MUSD

P/E

-1.4TTM

Div Yield

–ann

52W Range

34thpctl

Volume

0.45×avg

Market Cap

74.23MUSD

P/E Ratio

-1.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings